GPR88 and Parkinson disease: GPR88’s ability to modulate GABAergic and glutamatergic signaling positions it as a potential key regulator in PD pathophysiology, as disruptions in these neurotransmitter systems are implicated in the motor and cognitive symptoms of the disease [81].